NCT05969938 2023-08-01
Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology
Sun Yat-sen University
Unknown
Clinical Trials
12 trialsNCT05955079 2023-07-21
ctDNA-endo
Assistance Publique - Hôpitaux de Paris
Unknown
NCT05743959 2023-05-22
ctDNA Detection of MRD in Predicting Postoperative Recurrence in Biliary Tract Cancers：A Multicenter Prospective Trial
The First Affiliated Hospital with Nanjing Medical University
Unknown
NCT05578625 2022-10-13
ctDNA Methylation Sequencing for Myeloma
Institute of Hematology & Blood Diseases Hospital, China
Unknown
NCT05536700 2022-09-13
Using Mass Spectrometry (EasyM) Detecting Minimal Residual Disease (MRD) in Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China
Unknown
NCT05167604 2021-12-22
Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC
Tang-Du Hospital
Unknown
NCT03702088 2019-11-19
Place of the Hevylite Test in the Evaluation of MRD in Myeloma
University Hospital, Montpellier
Unknown
NCT04122092 2019-11-18
EUCADD
Shanghai Changzheng Hospital
Unknown
NCT03330769 2019-04-17
UPSTREAM
University of Cagliari
Unknown
NCT03413046 2018-01-29
The Effect of Chemotherapy on Regulatory T Cells
Ankara Children's Health and Diseases Hematology and Oncology Training and Research Hospital
Unknown
NCT02400827 2015-03-27
OVAMAR
University Hospital, Clermont-Ferrand
Unknown
NCT02400970 2015-03-27
TESTIMAR
University Hospital, Clermont-Ferrand
Unknown